https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Tildrakizumab Improves Signs, Symptoms of Active Psoriatic Arthritis in Phase 3 Studies

Tildrakizumab Improves Signs, Symptoms of Active Psoriatic Arthritis in Phase 3 Studies

Tildrakizumab 100 mg shows significant efficacy in treating psoriatic arthritis, achieving key clinical trial end points and offering hope for patients.

administrator

Related Articles